Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCB101 Combination Therapy in Advanced Gastric or GEJ Adenocarcinoma
NCT07680569Phase 2Not yet recruiting
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2027
01
Overview
A Phase 2 trial of HCB-101 in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
HCB-101
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT07680569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07680569.